CA2069869C - Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages - Google Patents
Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkagesInfo
- Publication number
- CA2069869C CA2069869C CA002069869A CA2069869A CA2069869C CA 2069869 C CA2069869 C CA 2069869C CA 002069869 A CA002069869 A CA 002069869A CA 2069869 A CA2069869 A CA 2069869A CA 2069869 C CA2069869 C CA 2069869C
- Authority
- CA
- Canada
- Prior art keywords
- base
- subunit
- morpholino
- polymer
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
- C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Peptides Or Proteins (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Saccharide Compounds (AREA)
- Polyamides (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45405789A | 1989-12-20 | 1989-12-20 | |
US454,057 | 1989-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2069869A1 CA2069869A1 (en) | 1991-06-21 |
CA2069869C true CA2069869C (en) | 1995-12-19 |
Family
ID=23803120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002069869A Expired - Lifetime CA2069869C (en) | 1989-12-20 | 1990-12-20 | Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP0962463B1 (ja) |
JP (2) | JP3398378B2 (ja) |
KR (1) | KR0167574B1 (ja) |
AT (2) | ATE220407T1 (ja) |
AU (1) | AU655164B2 (ja) |
CA (1) | CA2069869C (ja) |
DE (2) | DE69034213T2 (ja) |
WO (1) | WO1991009033A1 (ja) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166315A (en) * | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
US5405938A (en) * | 1989-12-20 | 1995-04-11 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
WO1998046740A1 (en) * | 1997-04-17 | 1998-10-22 | Antivirals, Inc. | Method of treating restenosis by antisense targeting of cmv |
US6365351B1 (en) * | 1999-01-29 | 2002-04-02 | Avi Biopharma, Inc. | Non-invasive method for detecting target RNA |
US20010024783A1 (en) * | 1999-01-29 | 2001-09-27 | Avi Biopharma, Inc. | Non-invasive method for detecting target RNA |
US6875747B1 (en) | 1999-05-24 | 2005-04-05 | Avi Bio Pharma, Inc. | Antisense to c-myc for treatment of polycystic kidney disease |
KR100708573B1 (ko) * | 1999-05-24 | 2007-04-18 | 에이브이아이 바이오파마 인코포레이티드 | 다낭 신장 질환의 치료를 위한 c-myc에 대한 안티센스 |
US6677153B2 (en) | 1999-11-29 | 2004-01-13 | Avi Biopharma, Inc. | Antisense antibacterial method and composition |
AU781676B2 (en) * | 2000-01-04 | 2005-06-02 | Avi Biopharma, Inc. | Antisense antibacterial cell division composition and method |
AU2005327188C8 (en) | 2004-07-02 | 2011-09-22 | Avi Biopharma, Inc. | Antisense antibacterial method and compound |
US8067571B2 (en) | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
SI2735568T1 (en) * | 2006-05-10 | 2018-01-31 | Sarepta Therapeutics, Inc. | Analogues of the oligonucleotide, with cationic links between subunits |
CN101861318A (zh) * | 2007-11-15 | 2010-10-13 | Avi生物制药公司 | 合成吗啉代低聚物的方法 |
NZ603606A (en) | 2010-05-28 | 2015-06-26 | Sarepta Therapeutics Inc | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups |
AU2013202731B2 (en) * | 2010-05-28 | 2016-04-21 | Sarepta Therapeutics, Inc. | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups |
TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
US10017763B2 (en) | 2010-09-03 | 2018-07-10 | Sarepta Therapeutics, Inc. | dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups |
ES2607603T3 (es) | 2010-09-30 | 2017-04-03 | Nippon Shinyaku Co., Ltd. | Derivado de ácido morfolino nucleico |
KR20140097398A (ko) * | 2011-11-18 | 2014-08-06 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | 기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트 |
IN2014DN06220A (ja) | 2011-12-28 | 2015-10-23 | Nippon Shinyaku Co Ltd | |
US9920085B2 (en) * | 2012-03-20 | 2018-03-20 | Sarepta Therapeutics, Inc. | Boronic acid conjugates of oligonucleotide analogues |
EP3015467A4 (en) | 2013-05-24 | 2016-11-02 | Ajinomoto Kk | PROCESS FOR THE PRODUCTION OF MORPHOLINO-OLIGONUCLEOTIDE |
RU2702424C2 (ru) | 2014-03-12 | 2019-10-08 | Ниппон Синяку Ко., Лтд. | Антисмысловые нуклеиновые кислоты |
TWI721461B (zh) | 2014-06-17 | 2021-03-11 | 日商日本新藥股份有限公司 | 反義核酸 |
EP3208277A4 (en) * | 2014-10-14 | 2018-06-13 | Ajinomoto Co., Inc. | Morpholino oligonucleotide manufacturing method |
JP6733554B2 (ja) | 2015-01-21 | 2020-08-05 | 味の素株式会社 | 沈殿促進剤およびそれを用いる沈殿化方法 |
EP3302489A4 (en) | 2015-06-04 | 2019-02-06 | Sarepta Therapeutics, Inc. | METHOD AND COMPOUNDS FOR THE TREATMENT OF DISEASES AND SUFFERING IN CONNECTION WITH LYMPHOCYTES |
MY185390A (en) | 2015-09-15 | 2021-05-17 | Nippon Shinyaku Co Ltd | Antisense nucleic acids |
WO2017047741A1 (ja) | 2015-09-16 | 2017-03-23 | 日本新薬株式会社 | 筋萎縮症治療用アンチセンス核酸 |
JP2019534862A (ja) * | 2016-09-20 | 2019-12-05 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド,ア ボディ コーポレイト | ホスホルアミダイト化学を使用する骨格修飾モルホリノオリゴヌクレオチド及びキメラの合成 |
JP7394749B2 (ja) | 2018-05-10 | 2023-12-08 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
KR20210023988A (ko) | 2018-06-26 | 2021-03-04 | 니뽄 신야쿠 가부시키가이샤 | 안티센스 올리고뉴클레오티드를 함유하는 조성물 및 듀시엔형 근이영양증의 치료로의 그의 사용 |
GB201821269D0 (en) | 2018-12-28 | 2019-02-13 | Nippon Shinyaku Co Ltd | Myostatin signal inhibitor |
CA3161589A1 (en) | 2019-11-13 | 2021-05-20 | Nippon Shinyaku Co., Ltd. | Method for producing oligonucleic acid compound |
US20230018780A1 (en) | 2019-11-13 | 2023-01-19 | Nippon Shinyaku Co., Ltd. | Method for producing oligonucleic acid compound |
IL293997A (en) | 2019-12-19 | 2022-08-01 | Nippon Shinyaku Co Ltd | Antistrand nucleic acids that allow exon skipping |
CN114901823A (zh) | 2019-12-26 | 2022-08-12 | 日本新药株式会社 | 诱导外显子50的跳读的反义核酸 |
KR20220145865A (ko) | 2020-02-28 | 2022-10-31 | 니뽄 신야쿠 가부시키가이샤 | 엑손 51의 스키핑을 유도하는 안티센스 핵산 |
EP4320138A1 (en) | 2021-04-09 | 2024-02-14 | Bachem Holding AG | Pseudo solid phase protecting group and methods for the synthesis of oligonucleotides and oligonucleotide conjugates |
CA3218264A1 (en) | 2021-04-28 | 2022-11-03 | Nippon Shinyaku Co., Ltd. | Method for producing oligonucleic acid compound |
JPWO2022239863A1 (ja) | 2021-05-13 | 2022-11-17 | ||
KR20240013202A (ko) | 2021-05-28 | 2024-01-30 | 스미토모 파마 가부시키가이샤 | 안티센스 핵산 |
TW202307208A (zh) | 2021-06-23 | 2023-02-16 | 日商日本新藥股份有限公司 | 反義寡聚物之組合 |
TW202308664A (zh) | 2021-07-08 | 2023-03-01 | 日商日本新藥股份有限公司 | 腎毒性減輕劑 |
AU2022306542A1 (en) | 2021-07-08 | 2024-01-18 | Nippon Shinyaku Co., Ltd. | Precipitation suppressing agent |
WO2023282345A1 (ja) | 2021-07-08 | 2023-01-12 | 日本新薬株式会社 | 腎毒性軽減剤 |
WO2023026994A1 (ja) | 2021-08-21 | 2023-03-02 | 武田薬品工業株式会社 | ヒトトランスフェリンレセプター結合ペプチド-薬物コンジュゲート |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE171185T1 (de) * | 1985-03-15 | 1998-10-15 | Antivirals Inc | Immunotestmittel für polynukleotid und verfahren |
-
1990
- 1990-12-20 EP EP99109726A patent/EP0962463B1/en not_active Expired - Lifetime
- 1990-12-20 WO PCT/US1990/007563 patent/WO1991009033A1/en active IP Right Grant
- 1990-12-20 EP EP91902085A patent/EP0506830B1/en not_active Expired - Lifetime
- 1990-12-20 AT AT99109726T patent/ATE220407T1/de not_active IP Right Cessation
- 1990-12-20 DE DE69034213T patent/DE69034213T2/de not_active Expired - Lifetime
- 1990-12-20 AU AU71642/91A patent/AU655164B2/en not_active Expired
- 1990-12-20 DE DE69033986T patent/DE69033986T2/de not_active Expired - Lifetime
- 1990-12-20 AT AT91902085T patent/ATE312834T1/de not_active IP Right Cessation
- 1990-12-20 JP JP50289191A patent/JP3398378B2/ja not_active Expired - Lifetime
- 1990-12-20 CA CA002069869A patent/CA2069869C/en not_active Expired - Lifetime
- 1990-12-20 KR KR1019920701479A patent/KR0167574B1/ko not_active IP Right Cessation
-
2001
- 2001-06-13 JP JP2001179272A patent/JP2002167441A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU7164291A (en) | 1991-07-18 |
EP0506830A4 (en) | 1993-01-07 |
DE69033986T2 (de) | 2003-03-13 |
ATE220407T1 (de) | 2002-07-15 |
DE69033986D1 (de) | 2002-08-14 |
EP0506830A1 (en) | 1992-10-07 |
EP0506830B1 (en) | 2005-12-14 |
CA2069869A1 (en) | 1991-06-21 |
KR920703584A (ko) | 1992-12-18 |
ATE312834T1 (de) | 2005-12-15 |
DE69034213D1 (de) | 2006-01-19 |
WO1991009033A1 (en) | 1991-06-27 |
EP0962463B1 (en) | 2002-07-10 |
KR0167574B1 (ko) | 1999-01-15 |
DE69034213T2 (de) | 2006-08-24 |
EP0962463A1 (en) | 1999-12-08 |
JP2002167441A (ja) | 2002-06-11 |
JP3398378B2 (ja) | 2003-04-21 |
AU655164B2 (en) | 1994-12-08 |
JPH05504563A (ja) | 1993-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2069869C (en) | Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages | |
US5185444A (en) | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages | |
US5521063A (en) | Polynucleotide reagent containing chiral subunits and methods of use | |
US5235033A (en) | Alpha-morpholino ribonucleoside derivatives and polymers thereof | |
US5034506A (en) | Uncharged morpholino-based polymers having achiral intersubunit linkages | |
US5378841A (en) | Alpha-morpholino ribonucleoside derivatives and polymers thereof | |
US5405938A (en) | Sequence-specific binding polymers for duplex nucleic acids | |
AU665560B2 (en) | Sequence-specific binding polymers for duplex nucleic acids | |
US5142047A (en) | Uncharged polynucleotide-binding polymers | |
CA2087818C (en) | Oligonucleotide analogs, their preparation and use | |
US5470974A (en) | Uncharged polynucleotide-binding polymers | |
KR100273824B1 (ko) | 비뉴클레오티드성 그룹을 갖는 3'-유도된 올리고뉴클레오티드 동족체, 이의 제조방법 및 이를 함유하는 약제학적 제제 | |
CA2019156A1 (en) | Formation of triple helix complexes of double stranded dna using nucleoside oligomers | |
EP0358657B1 (en) | Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides) | |
Ademola | Synthetic nucleotides and their biological applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |